ClinicalTrialsFinder

Indeterminate Lesions Clinical Trials

0 recruiting

Showing 1–2 of 2 trials

Recruiting
Phase 3

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

Uveal MelanomaChoroidal MelanomaIndeterminate Lesions+1 more
Aura Biosciences100 enrolled71 locationsNCT06007690
Recruiting

Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

Uveal MelanomaChoroidal MelanomaIndeterminate Lesions+1 more
Aura Biosciences15 enrolled1 locationNCT07421739